UAB "Biovyta" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 12,750 |
| 12,750 |
| 6,823 |
| 6,823 |
| 6,823 |
| 100.00 |
| 53.51 |
| 21,706 |
| 16,114 |
| 1,793 |
| 36,027 |
| 1.56 |
| 0.74 |
| - |
| - |
| 53.51 |
| 6,823 |
| 2023 |
|---|
| 1,032 |
| 1,032 |
| -14,149 |
| -14,149 |
| -14,149 |
| 100.00 |
| -1,371.03 |
| 7,557 |
| 11,935 |
| 345 |
| 19,147 |
| 6.99 |
| 1.58 |
| - |
| - |
| -1,371.03 |
| -14,149 |
| 2024 |
|---|
| 860 |
| 860 |
| -4,777 |
| -4,777 |
| -4,777 |
| -63.37 |
| -555.47 |
| 2,780 |
| 16,174 |
| 1 |
| 18,953 |
| 3.23 |
| 5.82 |
| - |
| - |
| -555.47 |
| -4,777 |
| 2024 |
|---|
| 860 |
| 860 |
| -4,777 |
| -4,777 |
| -4,777 |
| -63.37 |
| -555.47 |
| 2,780 |
| 16,174 |
| 1 |
| 18,953 |
| 3.23 |
| 5.82 |
| - |
| - |
| -555.47 |
| -4,777 |
Turnover (€)
2024
Turnover (€)
860 €-17 % *
Sales per employee (€)
860 €-17 % *
Profit before tax (€)
-4,777 €66 % *
Net Profit (€)
-4,777 €66 % *
Profit per employee (€)
-4,777 €66 % *
Total profitability (%)
-63.37 %-163.37 % *
Net profitability (%)
-555.47 %59.49 % *
Equity (€)
2,780 €-63 % *
Amounts Payable And Liabilities (€)
16,174 €36 % *
Non-current Assets (€)
1 €-100 % *
CurrentAssets (€)
18,953 €-1 % *
Working capital requirement
3.23 -53.79 % *
Debt-to-equity ratio
5.82 268.35 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-555.47 %59.49 % *
EBIT (€)
-4,777 €66 % *
